Sanofi posts positive results for drug in chronic sinusitis

PARIS, Sept 30 (Reuters) - Sanofi and its U.S. partner Regeneron on Tuesday unveiled positive mid-stage trial results for their experimental drug dupilumab in patients with chronic sinusitis with nasal polyps.